YounHaKimMD

Clinical Trials

• Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma Start of enrollment: 2001 Apr 01

  Completed

  Phase 1

• Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma Start of enrollment: 2007 Jan 01

  Terminated

  Phase 2

• Forodesine in the Treatment of Cutaneous T-Cell Lymphoma Start of enrollment: 2007 Jul 01

  Completed

  Phase 2

• Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma Start of enrollment: 2009 May 01

  Completed

  Phase 2

• Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides Start of enrollment: 2010 Dec 01

  Terminated

  Phase 1, Phase 2

• Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level Start of enrollment: 2011 May 01

  Completed

  Phase 2

• Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and Vomiting Start of enrollment: 2012 Jan 01

  Completed

  Phase 3

• Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL Start of enrollment: 2012 Nov 01

  Completed

  Phase 3

• NM-IL-12 in Cutaneous T-Cell Lymphoma (CTCL) Undergoing Total Skin Electron Beam Therapy (TSEBT) Start of enrollment: 2015 Dec 01

  Unknown status

  Phase 2

• Join now to see all